Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17B | O94768 | 1/20 | 0.46 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 7/20 | 0.43 |
| ▸ | CA1 | P00915 | 7/20 | 0.43 |
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | CA9 | Q16790 | 7/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24741984 | 0.85 | STK17B (0.49) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24742372 | 0.80 | CA12 (0.43) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24742549 | 0.80 | CA12 (0.42) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL27328190 | 0.79 | TDP1 (0.51) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL24741979 | 0.79 | CA1 (0.46) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24741948 | 0.76 | STK17B (0.47) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24743050 | 0.75 | CA12 (0.45) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24742199 | 0.75 | CA1 (0.47) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24742533 | 0.74 | CA12 (0.42) | STK17BSTK17ACA12CA1CA2 | |
| SCHEMBL24741843 | 0.74 | STK17B (0.47) | STK17BSTK17ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022206888-A1 | CDK2 INHIBITORS AND USE THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2022-10-06 | — | — | WO | disclosed |